| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:39 UTC |
|---|
| HMDB ID | HMDB0014509 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Grepafloxacin |
|---|
| Description | Grepafloxacin belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. Grepafloxacin is a drug which is used for treatment of adults with mild to moderate infections caused by susceptible strains of haemophilus influenzae, streptococcus pneumoniae, or moraxella catarrhalis. Based on a literature review a significant number of articles have been published on Grepafloxacin. |
|---|
| Structure | CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O InChI=1S/C19H22FN3O3/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26) |
|---|
| Synonyms | | Value | Source |
|---|
| Raxar | ChEMBL, HMDB | | Grepafloxacin hydrochloride | MeSH, HMDB | | Grepafloxacin HCL | MeSH, HMDB | | (+--)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid | MeSH, HMDB | | (+--)-1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid monohydrochloride | MeSH, HMDB |
|
|---|
| Chemical Formula | C19H22FN3O3 |
|---|
| Average Molecular Weight | 359.3947 |
|---|
| Monoisotopic Molecular Weight | 359.16451979 |
|---|
| IUPAC Name | 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|---|
| Traditional Name | grepafloxacin |
|---|
| CAS Registry Number | 119914-60-2 |
|---|
| SMILES | CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C19H22FN3O3/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26) |
|---|
| InChI Key | AIJTTZAVMXIJGM-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Quinolines and derivatives |
|---|
| Sub Class | Quinoline carboxylic acids |
|---|
| Direct Parent | Quinoline carboxylic acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Quinoline-3-carboxylic acid
- Fluoroquinolone
- N-arylpiperazine
- Aminoquinoline
- Haloquinoline
- Dihydroquinolone
- Dihydroquinoline
- Pyridine carboxylic acid
- Pyridine carboxylic acid or derivatives
- Tertiary aliphatic/aromatic amine
- Dialkylarylamine
- Aryl fluoride
- Aryl halide
- 1,4-diazinane
- Piperazine
- Pyridine
- Benzenoid
- Vinylogous amide
- Heteroaromatic compound
- Amino acid or derivatives
- Amino acid
- Tertiary amine
- Azacycle
- Secondary amine
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Secondary aliphatic amine
- Amine
- Organic oxygen compound
- Organic nitrogen compound
- Organopnictogen compound
- Organic oxide
- Organohalogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.63 g/L | Not Available | | LogP | 2.9 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.13 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.0968 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.33 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 148.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Grepafloxacin,1TMS,isomer #1 | CC1=C(F)C(N2CCNC(C)C2)=CC2=C1C(=O)C(C(=O)O[Si](C)(C)C)=CN2C1CC1 | 3461.0 | Semi standard non polar | 33892256 | | Grepafloxacin,1TMS,isomer #2 | CC1=C(F)C(N2CCN([Si](C)(C)C)C(C)C2)=CC2=C1C(=O)C(C(=O)O)=CN2C1CC1 | 3424.8 | Semi standard non polar | 33892256 | | Grepafloxacin,2TMS,isomer #1 | CC1=C(F)C(N2CCN([Si](C)(C)C)C(C)C2)=CC2=C1C(=O)C(C(=O)O[Si](C)(C)C)=CN2C1CC1 | 3389.9 | Semi standard non polar | 33892256 | | Grepafloxacin,2TMS,isomer #1 | CC1=C(F)C(N2CCN([Si](C)(C)C)C(C)C2)=CC2=C1C(=O)C(C(=O)O[Si](C)(C)C)=CN2C1CC1 | 3147.6 | Standard non polar | 33892256 | | Grepafloxacin,2TMS,isomer #1 | CC1=C(F)C(N2CCN([Si](C)(C)C)C(C)C2)=CC2=C1C(=O)C(C(=O)O[Si](C)(C)C)=CN2C1CC1 | 3598.4 | Standard polar | 33892256 | | Grepafloxacin,1TBDMS,isomer #1 | CC1=C(F)C(N2CCNC(C)C2)=CC2=C1C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN2C1CC1 | 3641.7 | Semi standard non polar | 33892256 | | Grepafloxacin,1TBDMS,isomer #2 | CC1=C(F)C(N2CCN([Si](C)(C)C(C)(C)C)C(C)C2)=CC2=C1C(=O)C(C(=O)O)=CN2C1CC1 | 3675.7 | Semi standard non polar | 33892256 | | Grepafloxacin,2TBDMS,isomer #1 | CC1=C(F)C(N2CCN([Si](C)(C)C(C)(C)C)C(C)C2)=CC2=C1C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN2C1CC1 | 3817.3 | Semi standard non polar | 33892256 | | Grepafloxacin,2TBDMS,isomer #1 | CC1=C(F)C(N2CCN([Si](C)(C)C(C)(C)C)C(C)C2)=CC2=C1C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN2C1CC1 | 3548.6 | Standard non polar | 33892256 | | Grepafloxacin,2TBDMS,isomer #1 | CC1=C(F)C(N2CCN([Si](C)(C)C(C)(C)C)C(C)C2)=CC2=C1C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN2C1CC1 | 3777.7 | Standard polar | 33892256 |
|
|---|